Therefore, the increasing trend of the antibiotic resistance due to beta-lactamase enzymes to commonly used antibacterial agents for the treatment of infections caused by P. aeruginosa and its current impact on antibacterial therapy failure encouraged us to find out the beta-lactamases mediated resistance rate and current antibiotic options for effective treatment of this organism. This evidence concerns the gene LACTB and infection.